Analyst Ratings For NewLink Genetics (NASDAQ:NLNK)
Today, Stifel Nicolaus reiterated its Buy rating on NewLink Genetics (NASDAQ:NLNK) with a price target of $21.00.
Some recent analyst ratings include
- 3/2/2018-Stifel Nicolaus Reiterated Rating of Buy.
- 10/13/2017-Bank of America initiated coverage with a Buy rating.
- 9/8/2017-Robert W. Baird Upgrade from a “Neutral ” rating to a ” Outperform” rating.
- 3/30/2017-SunTrust Banks Upgrade from a “Hold ” rating to a ” Buy” rating.
Recent Insider Trading Activity For NewLink Genetics (NASDAQ:NLNK)
NewLink Genetics (NASDAQ:NLNK) has insider ownership of 13.70% and institutional ownership of 54.58%.
- On 11/21/2017 Carl W. Langren, Insider, sold 2,229 with an average share price of $9.05 per share and the total transaction amounting to $20,172.45.
- On 10/6/2017 Stine Seed Farm, Inc., Major Shareholder, bought 780,487 with an average share price of $10.25 per share and the total transaction amounting to $7,999,991.75.
- On 3/15/2016 Charles J Jr. Link, CEO, sold 25,000 with an average share price of $17.86 per share and the total transaction amounting to $446,500.00.
- On 1/6/2016 Charles J. Jr. Link, CEO, sold 25,000 with an average share price of $32.53 per share and the total transaction amounting to $813,250.00.
- On 1/5/2016 Brian Wiley, VP, sold 1,295 with an average share price of $34.99 per share and the total transaction amounting to $45,312.05.
- On 1/5/2016 Carl W. Langren, insider, sold 1,095 with an average share price of $34.97 per share and the total transaction amounting to $38,292.15.
- On 1/5/2016 Charles J. Jr. Link, CEO, sold 5,001 with an average share price of $35.06 per share and the total transaction amounting to $175,335.06.
Recent Trading Activity for NewLink Genetics (NASDAQ:NLNK)
Shares of NewLink Genetics closed the previous trading session at 6.92 down -0.06 0.93% with shares trading hands.